Manulife Smart Dividend ... Share Price CDIV - Stock Quote, Charts, Trade History, Share Chat, Financials.

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
ETFs
Canada
TSX
Manulife Smart Dividend ETF (CDIV) Share Price

Manulife Smart Dividend ETF (CDIV)

15.04

0.02

(0.13%)

Closed 30 January 8:12AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

15.04

Bid

15.01

Offer

15.05

Volume

7,710

14.98 Day's Range 15.07

0.00 52 Week Range 0.00

Market Cap

Previous Close

15.02

Open

14.98

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

-

Dividend Yield

-

PE Ratio

0.00

Earnings Per Share (EPS)

-

Revenue

41.86M

Net Profit

40.73M

Sector

Finance Services

Industry

Finance Services

Website

www.manulifeim.ca

Headquarters

Toronto, Ontario, Can

Founded

-

Manulife Smart Dividend ETF is listed in the Finance Services sector of the Toronto Stock Exchange with ticker CDIV. The last closing price for Manulife Smart Dividend ... was $15.02. Over the last year, Manulife Smart Dividend ... shares have traded in a share price range of $ 0.00 to $ 0.00.

Manulife Smart Dividend ... currently has 0 shares in issue.

Gestion de placements Manuvie annonce les distributions réinvesties définitives de gains en capital pour les fonds négociés en bourse Manuvie et de la série FNB des Fonds Manuvie

Gestion de placements Manuvie annonce les distributions réinvesties définitives de gains en capital pour les fonds négociés en bourse Manuvie et de la série FNB des Fonds...

Manulife Investment Management Announces Estimated Cash Distributions for Manulife Exchange Traded Funds and ETF Series of Manulife Funds

Manulife Investment Management Announces Estimated Cash Distributions for Manulife Exchange Traded Funds and ETF Series of Manulife Funds Canada NewsWire TORONTO, Dec. 20, 2024 C$ unless...

Gestion de placements Manuvie annonce les distributions réinvesties estimatives de gains en capital pour les fonds négociés en bourse Manuvie et de la série FNB des Fonds Manuvie

Gestion de placements Manuvie annonce les distributions réinvesties estimatives de gains en capital pour les fonds négociés en bourse Manuvie et de la série FNB des Fonds...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ATHAlterity Therapeutics Ltd	AUD 0.016 (100.00%)	156.66M
VPRVolt Group Ltd	AUD 0.002 (100.00%)	4.91k
ATHOAlterity Therapeutics Limited	AUD 0.007 (75.00%)	32M
CBYCanterbury Resources Limited	AUD 0.033 (57.14%)	2.45M
88E88 Energy Limited	AUD 0.002 (33.33%)	3.33M
ERAEnergy Resources Of Australia Limited	AUD 0.002 (-33.33%)	333.33k
OB1Orbminco Ltd	AUD 0.0015 (-25.00%)	410.67k
NWMONorwest Minerals Limited	AUD 0.003 (-25.00%)	150k
LSRLodestar Minerals Limited	AUD 0.011 (-21.43%)	1.57M
ALVAlvo Minerals Ltd	AUD 0.049 (-18.33%)	64.69k
ATHAlterity Therapeutics Ltd	AUD 0.016 (100.00%)	156.66M
ATHOAlterity Therapeutics Limited	AUD 0.007 (75.00%)	32M
H2GGreenHy2 Ltd	AUD 0.003 (0.00%)	15.84M
BTRBrightstar Resources Limited	AUD 0.021 (5.00%)	13.69M
ZIPZip Co Limited	AUD 2.70 (-17.18%)	13.41M

Backstabbed

Backstabbed 5 minutes ago

25,000 shares x $0.20 = $5,000 USD

newmedman

newmedman 5 minutes ago

Hold on to the truth…
A recording from Jim Acosta's Substack live video
JIM ACOSTA
JAN 28, 2025
It was early March in 2007 when I received a phone call in the middle of the night. CNN’s bureau chief in New York at the time, Edith Chapin, called to deploy me to the Bronx o

MartinLutherKing

MartinLutherKing 5 minutes ago

https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors?

valuemind

valuemind 5 minutes ago

2025-2027 will be TSLA years!

jondoeuk

jondoeuk 6 minutes ago

The PR is an utter mess! The ORR across subgroups is higher, but the (m)PFS isn't that great.

MartinLutherKing

MartinLutherKing 6 minutes ago

FDA Approves TransCode's Phase 1/2 Trial of TTX-MC138 for Advanced Solid Tumors
18 April 2024
3 min read
TransCode Therapeutics, Inc., a specialist in RNA oncology, has revealed that the U.S. Food and Drug Administration has finished reviewing their Investigational New Drug appl

Backstabbed

Backstabbed 7 minutes ago

50,000 shares x $0.20 = $10,000 USD

Backstabbed

Backstabbed 8 minutes ago

100,000 shares x $0.20 = $20,000 USD

Backstabbed

Backstabbed 8 minutes ago

250,000 shares x $0.20 = $50,000 USD

ChartTRACKER

ChartTRACKER 8 minutes ago

$ADTX: Lay off the Kool-aid buddy!
250:1 😂 ! [You go that wrong too! You post is showing as a F/S]!!

A Company needs to maintain > 500k Shs to be listed on NASDAQ after a R/S.

Backstabbed

Backstabbed 9 minutes ago

500,000 shares x $0.20 = $100,000

Techroemancer

Techroemancer 9 minutes ago

Hopefully the momentum of the volume will continue to uptick. With the current O/S, we need some big volume days to get us out of the trips land. The financials and performance are phenomenal and once we can gain some traction/momentum, this should be easy to launch. Just need the interest/volume an

MartinLutherKing

MartinLutherKing 9 minutes ago

TTX-MC-138 targets miR-10b and has potential applications in the treatment of various cancers and diseases affecting different body systems. The drug is currently in Phase 1/2 of development and has been designated as an orphan drug, indicating its potential to address unmet medical needs in rare di

zab

zab 9 minutes ago

Trump's pandemic killed 1.3 million Americans, you must be so happy with his choice to downplay it.

Backstabbed

Backstabbed 9 minutes ago

1,000,000 shares x $0.20 = $200,000 USD

Backstabbed

Backstabbed 9 minutes ago

Cohen said $0.20 by May 2025! $ZHUD

stealofadeal

stealofadeal 10 minutes ago

$KRTL Another good day today. Thin share structure and going to move fast.

bb8675309

bb8675309 10 minutes ago

Hey Bourbon. Good to hear from you. Yes, it would be great if they brought back the uptick rule. Might help. Maybe that's the way market shorting was once done and is intended to work but today shorts are destroying good companies. I don't believe the retail investor has SEC protection in the market

Whalatane

Whalatane 10 minutes ago

Ha ha ...hope not . Usually analysts give 1 yr targets
Co will be hosting a commercialization day this Qt I think ...to show they are ready to launch as soon as approved
Kiwi

Ex-brokerBry

Ex-brokerBry 10 minutes ago

Ok Georgie18,do you have any idea who that seller is.?When will this end.Stocks have a tendency to go down slowly and then rise guickly.My Morgan Stanley has a final price after that 1 milly buy at the end at .0457....I've been burned with these kind of stocks.If it drops below .03 I'm buying more.Y

jondoeuk

jondoeuk 10 minutes ago

We won't know until it is tested, but from this: 'We found activated CD19 CAR.ADR T cells have lower levels of detectable 4-1BB on their surface compared to CD19 CAR T cells, suggesting partial downregulation or masking of 4-1BB upon ADR expression (Supplementary Fig. 9a). Indeed, expression of a tr

nowwhat2

nowwhat2 11 minutes ago

What a performance eh ?.......How's about THAT ?

https://investorshub.advfn.com/uimage/uploads/2025/1/29/bghbxBTC_!_29_15d_930am_fomc_deep_import.jpg

https://investorshub.advfn.com/uimage/uploads/2025/1/29/ipgjvbtc_!_29_15d_2pm_FOMC_update_100k.jpg

valuemind

valuemind 11 minutes ago

NXT outperformed FSLR nearly 50% in the past 3 months. Stock selection is apparently more important than industry selection.

Manulife Smart Dividend ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions